SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $4,050 | +15.2% | 42 | +44.8% | 0.00% | – |
| Q3 2023 | $3,515 | -12.3% | 29 | -17.1% | 0.00% | – |
| Q2 2023 | $4,008 | -3.1% | 35 | +16.7% | 0.00% | – |
| Q1 2023 | $4,135 | +103275.0% | 30 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 30 | +11.1% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 27 | +285.7% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 7 | -22.2% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 9 | -43.8% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 16 | +77.8% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -100.0% | 9 | -90.0% | 0.00% | -100.0% |
| Q4 2018 | $9,822,000 | -50.2% | 90 | -26.2% | 0.00% | 0.0% |
| Q3 2018 | $19,704,000 | +20.2% | 122 | -1.6% | 0.00% | 0.0% |
| Q2 2018 | $16,390,000 | +78.4% | 124 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $9,187,000 | +725.4% | 124 | +520.0% | 0.00% | – |
| Q4 2017 | $1,113,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |